The PINK PILL for Women's Sexual Desire - Why it Took 10x Longer for Women's Addyi vs Men's Viagara with Cindy Eckert & Julie Bristow

The PINK PILL for Women's Sexual Desire - Why it Took 10x Longer for Women's Addyi vs Men's Viagara with Cindy Eckert & Julie Bristow

March 17, 2026 · 17 min · Episode 69

About this episode

The episode discusses the challenges and cultural implications surrounding the development of Addyi, the first FDA-approved medication for women's low libido, featuring insights from industry experts.

In today’s episode of Bite Back with Abbey Sharp, we explore the politics, science, and cultural debate surrounding women’s sexual desire and the development of the first FDA-approved medication for low libido. Joined by Julie Bristow, executive producer of the documentary The Pink Pill: Sex, Drugs, and Who Has Control, and Cindy Eckert, founder of Sprout Pharmaceuticals, we unpack the long road to bringing Addyi to market and what the fight for a “female Viagra” reveals about gender bias in medicine, sexual autonomy, and whose health needs are prioritized.

People in this episode

Host: Abbey Sharp

Guests: Cindy Eckert, Julie Bristow

Topics covered

Keywords

Mentioned in this episode

Organizations: Sprout Pharmaceuticals

Products: Addyi, Viagra

Books & works: The Pink Pill: Sex, Drugs, and Who Has Control

More episodes of Bite Back with Abbey Sharp

Explore listener stats, chart rankings, contacts and more on the Bite Back with Abbey Sharp podcast page.